TY - JOUR
T1 - A patient with congenital hypothyroidism due to a PAX8 frameshift variant accompanying a urogenital malformation
AU - Tanase-Nakao, Kanako
AU - Muroya, Koji
AU - Adachi, Masanori
AU - Abe, Kiyomi
AU - Hasegawa, Tomonobu
AU - Narumi, Satoshi
N1 - Funding Information:
We thank Dr. Kazuyuki Yamamoto and Dr. Saki Noda (Ichinomiya Municipal Hospital) for providing the clinical information. This work was supported by JSPS KAKENHI grant Number 22K16420.
Funding Information:
This work was supported by JSPS KAKENHI grant Number 22K16420.
Publisher Copyright:
© 2022 by The Japanese Society for Pediatric Endocrinology.
PY - 2022/10
Y1 - 2022/10
N2 - PAX8 is a transcription factor that is expressed in the thyroid gland and kidneys. Monoallelic loss-of-function PAX8 variants cause congenital hypothyroidism (CH), and urogenital malformations are infrequent complications seen in less than 10% of PAX8 variant carriers. Herein, we report the case of a 3-yr-old female patient with CH who was diagnosed during newborn screening. She was treated with levothyroxine, and she showed normal growth and development at a minimal dose (0.7 µg/kg/d of levothyroxine at 3 yr of age). At 5 mo of age, she visited an emergency department for fever and was incidentally found to have differently sized kidneys by ultrasonography, which was subsequently diagnosed as unilateral multicystic dysplastic kidney. Her serum creatinine and cystatin C levels were normal. Next-generation sequencing-based genetic analysis revealed that the patient was heterozygous for a PAX8 frameshift variant (p.Thr320ProfsTer106) and a DUOX2 missense variant (p.Arg885Gln). Our patient is the first truncating PAX8 variant carrier to have a urogenital malformation with CH. Genetic analysis for PAX8 should be considered in patients with CH and urogenital malformations.
AB - PAX8 is a transcription factor that is expressed in the thyroid gland and kidneys. Monoallelic loss-of-function PAX8 variants cause congenital hypothyroidism (CH), and urogenital malformations are infrequent complications seen in less than 10% of PAX8 variant carriers. Herein, we report the case of a 3-yr-old female patient with CH who was diagnosed during newborn screening. She was treated with levothyroxine, and she showed normal growth and development at a minimal dose (0.7 µg/kg/d of levothyroxine at 3 yr of age). At 5 mo of age, she visited an emergency department for fever and was incidentally found to have differently sized kidneys by ultrasonography, which was subsequently diagnosed as unilateral multicystic dysplastic kidney. Her serum creatinine and cystatin C levels were normal. Next-generation sequencing-based genetic analysis revealed that the patient was heterozygous for a PAX8 frameshift variant (p.Thr320ProfsTer106) and a DUOX2 missense variant (p.Arg885Gln). Our patient is the first truncating PAX8 variant carrier to have a urogenital malformation with CH. Genetic analysis for PAX8 should be considered in patients with CH and urogenital malformations.
KW - PAX8
KW - congenital hypothyroidism
KW - frameshift mutation
KW - urogenital abnormality
UR - http://www.scopus.com/inward/record.url?scp=85139388561&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139388561&partnerID=8YFLogxK
U2 - 10.1297/cpe.2022-0030
DO - 10.1297/cpe.2022-0030
M3 - Article
AN - SCOPUS:85139388561
SN - 0918-5739
VL - 31
SP - 250
EP - 255
JO - clinical pediatric endocrinology
JF - clinical pediatric endocrinology
IS - 4
ER -